Intero Biosystems wants drugmakers to test on mini human intestines, not animals
Source:
techcrunch
October 14, 2026 · 16:00
From the publisher
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
About the source
TechCrunch
TechCrunch is an American global online newspaper focusing on topics regarding high-tech and startup companies. It was founded in June 2005 by Archimedes Ventures, led by partners Michael Arrington and Keith Teare. In 2010, AOL acquired the company for approximately $25 million. Following the 2015 acquisition of AOL and Yahoo! by Verizon, the site was owned by Verizon Media from 2015 through 2021.
Wikidata Q1022366
Wikidata ↗
The original article opens on the publisher's website.
More from General
View topic →Jim Cramer says don't give up on this unpredictable market. Here's why
cnbc
Oct 14, 2026 · 15:19
Ambani’s Jio seeks to raise $3.2B in what could be India’s biggest IPO
techcrunch
Oct 14, 2026 · 14:48
Flock CEO says its microphones detect ‘just gunshots.’ Its website says different
techcrunch
Oct 14, 2026 · 14:30
Battle Over the Pierre Ends in Defeat for the Buyer Pushed by Lutnick
nytimes
Oct 14, 2026 · 14:12
OpenAI sued by 8 states over ChatGPT safety concerns
cnbc
Oct 14, 2026 · 14:09